[GLP-1 receptor activation effects the p38MAPK signal pathway in hepatic stellate cells]

Zhonghua Gan Zang Bing Za Zhi. 2015 Feb;23(2):130-3. doi: 10.3760/cma.j.issn.1007-3418.2015.02.011.
[Article in Chinese]

Abstract

Objective: To investigate the effects of activation of the GLP-1 receptor on the p38MAPK signaling pathway in hepatic stellate cells (HSCs).

Methods: HSCs were isolated and identified according to morphological features; the levels of GLP-1R protein were determined by western blotting.The HSCs were randomly divided into a control grouP (normal saline treatment) and experimental grouP(liraglutide treatment); after 120 hours, the expression of p38MAPK mRNA was examined by RT-PCR and of phosphorylated (p)-p38MAPK protein was detected by western blotting.

Results: GLP-1R proteins were detected in the HSCs. Compared with the control group, the experimental group showed significantly decreased p38MAPK mRNA and p-p38MAPK protein (both P < 0.01).

Conclusion: The p38MAPK signaling pathway could be down-regulated when GLP-1R is activated in HSCs.

MeSH terms

  • Cells, Cultured
  • Glucagon-Like Peptide 1 / analogs & derivatives
  • Glucagon-Like Peptide 1 / pharmacology
  • Glucagon-Like Peptide-1 Receptor
  • Hepatic Stellate Cells / metabolism*
  • Humans
  • Liraglutide
  • MAP Kinase Signaling System*
  • RNA, Messenger
  • Receptors, Glucagon / metabolism*
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • GLP1R protein, human
  • Glucagon-Like Peptide-1 Receptor
  • RNA, Messenger
  • Receptors, Glucagon
  • Liraglutide
  • Glucagon-Like Peptide 1
  • p38 Mitogen-Activated Protein Kinases